High-volume tasks like IP docketing can become overwhelming, meaning work on patent analytics and designing new services can suffer. BASF’s IP group trusts Evalueserve to support it with this sensitive work. Justin Delfino tells us why.
Shekhar Khanduja, raises search quality by pairing ‘Explorers’ and ’Planners’ on his team to different IP and R&D use cases with some fascinating results! This new post is the first of many showing how to control the factors in our ‘Search Quality Index’.
Ashutosh Pande and Urs Dommann discuss economics of patent searching; and introduce an initial formula describing search quality (“search quality index”). Let’s get serious with understanding search quality.
Much of the value offered by IP search services is helping customers to identify the most relevant data sources, without getting distracted by the irrelevant. But this can come at a cost. Urs Dommann and Ashutosh Pande explain the searcher’s dilemma.
If you could clone the ‘perfect searcher’, what kind of personality, experience and profile would you specify to optimize patent search quality? Urs Dommann reflects on the human factors of knowledge management, and how machines fill the inevitable gaps.
Is it possible to deliver a perfect IP and R&D search, i.e., a novelty or validity search that finds 100% of the relevant documents? Urs Dommann tells the story of seeing it achieved and explains why the method can’t be repeated.
The Head of Evalueserve’s IPR&D business Urs Dommann launches our Information Adventurers blog with a fundamental and provocative question. What constitutes a good IP and R&D search or intelligence?
An engineering simulation software company based in the US wanted to improve the level of engagement with its customers, recognizing a lack of targetable customer personas and an incomplete picture of the customer journey.
You could unlock deeper insights and higher ROI by combining spend information with other datasets and moving up to higher-order analytics.
Evalueserve created an expert team that could adapt as needed, covering docketing and paralegal tasks. Evalueserve also brought in the expertise to optimize existing processes to ensure greater productivity.
Automation is the most popular trend in today’s world of business. It is general consensus that automation increases productivity, leads to higher returns, and makes life better, but there are broader differences on how it will impact employment levels and society as a whole. The big question is: are we prepared to deal with its implications?
China is in the lead in the global digital environment. Read our article to find out why companies across the globe should pay attention to this country’s digital revolution.
Investment in technology is not enough for successful digital transformation or how your customers perceive you as a brand.
Managing customer churn is vital to business performance. As is researched and proven, a 5% improvement in customer retention rates increases profitability by 25 to close to 95%, as it is many times more expensive to acquire new customers than it is to retain an existing one.
The client found it challenging to identify key controllable and uncontrollable factors that drive customer churn at the dealer level. This in turn made it impossible to develop effective strategies to reduce churn.
A lot of books have been published on the topics of analytics and big data, particularly over the past decade. In this blog post, our author Mahesh recommends three of them.
Are you part of the global pharma conversation? Do you have the systems in place to join it? More and more pharmaceutical and healthcare companies are finding the need to actively engage with patients, physicians and key opinion leaders.
In his second video, our CEO Marc Vollenweider talks about the four benefits of our mind+machine strategy for our clients: 1) Productivity increases 2) Reduce time-to-market 3) Quality improvements 4) Provide new capabilities to give our clients an edge in the market.
See the list of 10 must-watch TED Talks on mind+machine™ in our latest blog entry.
Evalueserve’s strategy is based on mind+machine. Now, what is mind+machine?
Database subscription management is a high-priority activity for financial services firms.
There has been a flood of books on this topic in the last year or two. We have compiled a reading list of the top business books on automation and the future of work.
Business Insider recently ran an interesting post on this topic based on the results published from an algorithm by ExecRank.
These days, the popular media are full of articles about machines that use big data to perform almost any task without human intervention. But is this really true?
Evalueserve provides a dedicated offshore research desk for a leading third-party global logistics firm’s competitive and market intelligence (CMI) team.
Evalueserve offers a unique combination of logistics domain knowledge, proven best practices for sales engagements and a mind+machine approach for scalability to deliver a comprehensive view of the various delivery & supply chain influencers such as warehousing hubs, demand hubs, transportation cost, cost per supply chain activity and more.
EduVision Retail Technologies Pvt Ltd, which runs educational products aggregator Fastudent, has raised an undisclosed amount of seed investment from a group of angel investors led by Evalueserve COO Ashish Gupta.
Maintaining the headcount and in-house expertise to deal with the full range of IP administration tasks is costly. Our highly trained paralegals and specialists in patent drafting and prosecution are prepared to cover your needs. We can also support you with the business-critical transition from transactional to strategic IP management.
Using dedicated tools and models, our experts will help you gain deeper insights about your competitors, prospects and target industries.
Identifying the right opportunities to drive customer engagement is crucial to sustaining a high organic growth rate.
Aware of the potential of social media as a source of marketing, strategy, and adverse event information, a major pharmaceutical company wanted to invest in AOL.
